Searchable abstracts of presentations at key conferences on calcified tissues

ba0003pp215 | Osteoporosis: evaluation and imaging | ECTS2014

Bone quality in diabetes mellitus type 2

Jackuliak Peter , Killinger Zdenko , Payer Juraj

Diabetes is associated with increased risk of fracture, although type 2 diabetes mellitus (T2DM) is characterized by normal bone mineral density (BMD). Thus, diabetes may be associated with a reduction of bone strength that is not reflected in the measurement of BMD. It is very problematic to measure the bone quality in daily practice. Trabecular bone score (TBS) iNsight® is one of these tools, now available for routine clinical practice, that allows for refinement of mic...

ba0003pp337 | Osteoporosis: treatment | ECTS2014

Monitoring of calcium intake and vitamin D saturation in Slovak postmenopausal women

Vanuga Peter , Tomkova Sona , Jackuliak Peter , Killinger Zdenko , Payer Juraj

According various guidelines the basic recommendation in prevention and treatment of postmenopausal osteoporosis (PMO) is adequate intake of calcium (1000– 1300 mg/day) and vitamin D (800–1000 IU/day).Aim: To determine the intake dose of calcium and also the vitamin D saturation in women treated for PMO.Patients and methods: 465 women with PMO, divided into two groups: patients with newly diagnosed osteoporosis (n</em...

ba0001w6.1 | Cancer cells and Bone | ECTS2013

How do cancer cells home to and engage in bone?

Croucher Peter

A number of cancers develop in the skeleton or will metastasize to bone, including multiple myeloma and solid tumours such as breast and prostate cancer. Once established in the skeleton, cancer cells have the ability to modify the environment and cause devastating bone disease. The last decade has seen considerable progress in defining the critical cellular and molecular mechanisms responsible and also identified new roles for the cells of bone in the pathogenesis of metastas...

ba0004is3 | (1) (1) | ICCBH2015

Bone material properties

Fratzl Peter

Our skeleton needs to carry the body weight and to resist mechanical impacts. This capability or, conversely, bone fragility are controlled by the amount of bone mass, the shape and internal architecture of the bones, as well as by the material of which they are built. Bone material consists of a complex multi-scale arrangement of mineralized collagen fibrils containing also water, proteoglycans as well as some non-collagenous proteins. This organization is by no means constan...

ba0004is3biog | (1) (1) | ICCBH2015

Bone material properties

Fratzl Peter

Biographical DetailsPeter Fratzl is director at the Max Planck Institute of Colloids and Interfaces in Potsdam, Germany, and honorary professor at Humboldt University Berlin and Potsdam University. He holds an engineering degree from Ecole Polytechnique in Paris, France, and a doctorate in Physics from the University of Vienna, Austria. His scientific interests include the relation betwee...

ba0004is23 | (1) (1) | ICCBH2015

Multiphoton microscopy

Dondossola Eleonora , Friedl Peter

Multiphoton microscopy (MPM) is a powerful approach to visualize live cells and tissues, including bone, in three dimensions and over time. To enable preclinical longitudinal monitoring of bone by intravital MPM we developed an animal window model of bone using existing tissue engineering strategies. Electrospun polycaprolactone scaffolds and human mesenchymal stem cells after osteoblastic differentiation, in vitro, were implanted into the mouse skin in the presence o...

ba0004is23biog | (1) (1) | ICCBH2015

Multiphoton microscopy

Dondossola Eleonora , Friedl Peter

Biographical DetailsEleonora Dondossola is a Senior Postdoctoral Fellow in the Intravital Imaging Lab, Koch Center for Applied Research in Genitourinary Cancers, the University of Texas MD Anderson Cancer Center, Houston, TX, USA. She received her PhD in Cell and Molecular Biology from S. Raffaele Vita-Salute University, Milan, Italy, in 2010. Her current research is focused on metastasis...

ba0004p40 | (1) | ICCBH2015

Painful hip in 19-months old represents an intertrochanteric fracture following a low energy injury

Peev Peter , Obretenov Vasil

Hip fractures in children are extremely rare and account for less than 1% of all fractures in children. Most orthopaedic surgeons will treat only a few such fractures in a lifetime. They are associated with high complication rate because the vascular and osseous anatomy of the child’s proximal femur is vulnerable to injury. Knowledge of the blood supply to the immature proximal femoral epiphysis is necessary to adequately manage these injuries. Hip pain in children is a d...

ba0001oc1.5 | Osteoporosis epidemiology and long term treatment complications | ECTS2013

Heart failure in patients treated with bisphosphonates

Grove Erik , Abrahamsen Bo , Vestergaard Peter

Background: Bisphosphonates are widely used to prevent and treat osteoporosis. Limited evidence suggest that these drugs may reduce mortality, perhaps by protecting against cardiovascular disease. This study investigated the occurrence of heart failure in patients treated with bisphosphonates.Methods: Nationwide retrospective cohort study from Denmark. All users of bisphosphonates and raloxifene (n=4.831) between 1996 and 2006 (n=102.34...